Eva M. García‐Cuesta

AI is a viable alternative to high throughput screening: a 318-target study

Izhar Wallach, Denzil Bernard, Kong T. Nguyen et al. · Scientific Reports · 2024 · 120 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +16

Separating Actin-Dependent Chemokine Receptor Nanoclustering from Dimerization Indicates a Role for Clustering in CXCR4 Signaling and Function

Laura Martínez‐Muñoz, José Miguel Rodríguez‐Frade, Rubén Barroso et al. · Molecular Cell · 2018 · 110 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors

Sheila López‐Cobo, Natalia Pieper, Carmen Campos‐Silva et al. · OncoImmunology · 2017 · 68 citations · Full text

Life Sciences, Oncology, Pharmacology +17

NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation

Eva M. García‐Cuesta, Mario Álvarez‐Maestro, Gloria Esteso et al. · Frontiers in Immunology · 2015 · 44 citations · Full text

Life Sciences, Immunology, Oncology +17

Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes

Eva M. García‐Cuesta, Gloria Esteso, Omodele Ashiru et al. · OncoImmunology · 2017 · 39 citations · Full text

Life Sciences, Immunology, Oncology +17